# Drug Discovery Analysis Plan: From Marker Genes to Therapeutic Targets

## Overview
This plan outlines a systematic workflow using kb-mcp tools to identify drug discovery opportunities starting from marker genes identified in single-cell RNA-seq clusters.

## Workflow Steps

### 1. Gene ID Conversion and Validation
**Tools:** `get_ensembl_id_from_gene_symbol`, `get_uniprot_id_by_protein_symbol`

- Convert marker gene symbols to Ensembl IDs (required for Open Targets)
- Obtain UniProt IDs for protein-level analysis
- Validate gene symbols and handle synonyms

### 2. Pathway and Functional Analysis
**Tools:** `get_reactome_info_by_identifier`, `get_kegg_id_by_gene_symbol`, `query_kegg`

- Identify Reactome pathways enriched in marker genes
- Map genes to KEGG pathways (disease pathways, signaling pathways)
- Prioritize pathways relevant to disease mechanisms

### 3. Protein-Protein Interaction Network
**Tools:** `get_string_id`, `get_string_interactions`, `get_string_network_image`

- Build interaction networks for marker gene proteins
- Identify hub proteins and key interactors
- Visualize network topology to identify druggable nodes

### 4. Disease Association Analysis
**Tools:** `get_efo_id_by_disease_name`, `query_open_targets_graphql`

- Query Open Targets for disease associations with marker genes
- Identify diseases where these genes are validated targets
- Assess target-disease association scores and evidence

### 5. Drug Target Identification
**Tools:** `search_drugs_fda`, `get_drug_by_application_number`, `get_drug_label_info`

- Search FDA-approved drugs targeting marker gene products
- Identify existing therapeutics (repurposing opportunities)
- Find drugs by mechanism of action related to marker pathways

### 6. Clinical Trial Assessment
**Tools:** `get_studies_by_condition`, `get_studies_by_intervention`, `get_study_details`

- Search for active clinical trials targeting marker genes/proteins
- Identify trials testing relevant interventions
- Assess trial phases and recruitment status

### 7. Target Tractability and Validation
**Tools:** `get_human_protein_atlas_info`, `get_open_targets_graphql`

- Assess target tractability scores (Open Targets)
- Evaluate protein expression patterns (Human Protein Atlas)
- Review genetic constraint and safety profiles

### 8. Reagent and Tool Identification
**Tools:** `get_antibody_list`, `get_antibody_information`

- Identify available antibodies for marker gene products
- Find research reagents for target validation studies

## Output Summary
For each marker gene cluster, generate:
- **Target Prioritization**: Ranked list of druggable targets
- **Pathway Context**: Key pathways and biological processes
- **Drug Opportunities**: Existing drugs and repurposing candidates
- **Clinical Landscape**: Active trials and therapeutic development status
- **Validation Strategy**: Recommended antibodies and reagents

## Key Decision Points
1. **Target Selection**: Prioritize targets with high disease association scores and tractability
2. **Pathway Focus**: Concentrate on pathways with multiple marker genes (cluster-specific signatures)
3. **Drug Strategy**: Balance between novel targets and repurposing opportunities
4. **Validation**: Ensure targets have available reagents and clear disease associations

